Woodline Partners’s Guardian Pharmacy Services GRDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$49.2M Buy
1,306,318
+252,412
+24% +$8.25M 0.19% 139
2025
Q4
$31.7M Hold
1,053,906
0.12% 213
2025
Q3
$27.6M Buy
1,053,906
+528
+0.1% +$12.6K 0.13% 214
2025
Q2
$22.4M Buy
1,053,378
+632,175
+150% +$14.3M 0.12% 253
2025
Q1
$8.95M Buy
421,203
+6,083
+1% +$125K 0.06% 378
2024
Q4
$8.41M Sell
415,120
-153,011
-27% -$3.16M 0.06% 385
2024
Q3
$9.54M Buy
+568,131
New +$9.57M 0.08% 301

Other funds holding GRDN

Woodline Partners's GRDN Position: Q1 2026 in Review

Woodline Partners increased its Guardian Pharmacy Services (GRDN) stake by 24% in Q1 2026, buying an estimated $8.25M and bringing the position to 1,306,318 shares worth $49.2M. The position accounts for 0.19% of the portfolio, ranked #139.

Woodline Partners first reported a position in GRDN in Q3 2024 and has held it in 7 quarters since. 171 funds tracked by Wall St. Rank hold GRDN as of Q1 2026.

  • Woodline Partners held 1,306,318 shares of Guardian Pharmacy Services worth $49.2M as of Q1 2026.
  • Woodline Partners bought 252,412 Guardian Pharmacy Services shares in Q1 2026, an estimated $8.25M.
  • Guardian Pharmacy Services made up 0.19% of Woodline Partners's portfolio in Q1 2026, its #139 holding.
  • Woodline Partners first reported a position in Guardian Pharmacy Services in Q3 2024 and has held it in 7 quarters since.
  • 171 funds tracked by Wall St. Rank held Guardian Pharmacy Services as of Q1 2026.

Based on Woodline Partners's 13F filing for Q1 2026, filed 15 May 2026.